Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to learn more about what causes insulin resistance. It has been suggested that proper breakdown of fat into energy (oxidation) in the body is important to allow insulin to keep blood sugar in the normal range. The investigators want to know if having one of the fatty acid oxidation disorders could have an influence on insulin action. Fatty acid oxidation disorders are genetic disorders that inhibit one of the enzymes that converts fat into energy. The investigators will study both normal healthy people and people with a long-chain fatty acid oxidation disorder.


Clinical Trial Description

The overall goal of this proposal is to investigate the effects of disordered mitochondrial fatty acid oxidation on insulin resistance in humans. Mitochondrial dysfunction has been implicated in the development of insulin resistance and type 2 diabetes during excess dietary fat intake and from increased release of endogenous free fatty acids , such as occurs in obesity. Controversy exists, however, as to whether this insulin resistance results from intrinsic defects in mitochondrial energy utilization or from abnormalities resulting from excess free fatty acid flux, as well as the role that subsequent accumulation of cellular metabolic intermediates play in impaired insulin signaling. To address these controversies, the investigators will study a unique population of patients with inherited defects in each of the three mitochondrial enzymes in the fatty acid oxidation pathway: 1) very long-chain acyl-CoA dehydrogenase (VLCAD); 2) trifunctional protein (TFP, which includes long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD)); and 3) medium-chain acyl-CoA dehydrogenase (MCAD). These proteins are required for the oxidation of sequentially shorter fatty acids . The investigators will test the hypothesis that intrinsic defects in mitochondrial function involving oxidation of long-chain, but not medium-chain, fatty acids are sufficient to prevent intralipid-induced insulin resistance. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02517307
Study type Interventional
Source Oregon Health and Science University
Contact
Status Completed
Phase N/A
Start date February 2016
Completion date March 2021

See also
  Status Clinical Trial Phase
Completed NCT02922933 - A Study to Examine the Effect of Omeprazole, Famotidine, and an Acidic Beverage on the Pharmacokinetics of Entinostat in Healthy Adult Subjects Phase 1
Completed NCT02922946 - Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat Phase 1
Completed NCT01250197 - Formulation Comparison in Normal Volunteers Phase 1
Completed NCT02051517 - Vitreous Chemistry Analysis N/A
Completed NCT01185418 - Evaluation of Negative Symptoms and Cognitive Function After Administration of Antipsychotics in Healthy Volunteer N/A
Recruiting NCT00182858 - Tissue Procurement for Biomedical Research
Completed NCT02828813 - Neural Mechanisms of Motor and Cognitive Networks
Completed NCT02146391 - Study to Evaluate the Effect of Food Upon the Pharmacokinetics of Androxal Phase 1
Terminated NCT00465842 - Protein Biomarker in Hepatocellular Carcinoma
Recruiting NCT02471352 - Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
Terminated NCT01752231 - Optimization of Novel DCE-MRI Imaging Sequences for Cancer Therapy Monitoring N/A
Completed NCT01366352 - Pharmacokinetics and Bioavailability Comparison of Two Different Formulations of MNTX Tablets Phase 1
Not yet recruiting NCT01487486 - Proteomics & Glyco-Proteomic Analysis of Follicular Fluid N/A
Completed NCT03993587 - The Effect of Head and Shoulder Positioning on the Cross-sectional Area of the Subclavian Vein in Obese Adults
Completed NCT02860351 - The Effect of Head Positioning on the Cross-sectional Area of the Subclavian Vein. N/A
Completed NCT02113943 - Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Citalopram on Motivation Phase 2